CMS Issues Proposed Rule to Cover ‘Breakthrough’ Medical Devices

News
Published on:
August 11, 2020

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule this week that would give breakthrough medical devices national Medicare coverage on the same day they receive FDA approval for four years. The proposed rule, called Medicare Coverage of Innovative Technology (MCIT), would establish a Medicare coverage pathway that provides beneficiaries nationwide with faster access to new, innovative medical devices designated as ‘breakthrough’ by the Food and Drug Administration (FDA).

During the four year timeframe, CMS recommends that manufacturers develop additional evidence showing the applicability of their products to Medicare beneficiaries so they can apply for further coverage.

Before the MCIT, after a breakthrough technology receives FDA approval, an often lengthy and costly process for Medicare coverage begins. That period has been challenging for companies because innovators spent time and resources to achieve FDA approval, only to need to spend more time and money to acquire Medicare coverage. This lag time is not only costly but has also reduced access to innovative technologies by senior populations.

This proposed rule follows up on creating a pathway to Medicare coverage the same day as FDA market authorization for breakthrough devices. The proposal will be live from September 1, 2020 and open for comment till October 30, 2020. Additionally, the proposed rule would allow Medicare to cover eligible breakthrough devices the FDA has approved for use in 2019 or 2020.

What does it mean for you?

Organizations will need to understand the details of the breakthrough designation and how it applies to their innovation before proceeding. Moreover, what evidence needs to be generated in these four years to maintain coverage. The Alira Health team can help you understand how this designation applies to you, and how you can best leverage the proposed rule for your innovation.

For more information, please contact Deepak Sahu.

Click here to see the proposed rule from The Department of Health and Human Services.

Related news

News February 7, 2023
The 2023 MedTech Contract Manufacturing Report is released in the U.S.
Alira Health, a global healthcare advisory, clinical research and technology company, announced today the release of the 2023 U.S. MedTech Contract Manufacturing Report in collaboration(...)
MedTech
Publications February 7, 2023
The 2023 U.S. Medtech Contract Manufacturing Report
Read this report to discover the trends in the world of medical device CDMOs and their meaning for the industry.
MedTech
Publications February 2, 2023
Outlook 2023: Firms Prepare For ‘World Where Health Care Has No Limits’
In the latest publication by Medtech Insights by Pharma Intelligence, executives at top device companies and other stakeholders share their expectations.
MedTech Pharma
News January 31, 2023
The Playbook for Patient Engagement in MedTech in the U.S. is Launched
The MedTech Patient Engagement Think Tank announced today the launch of the Playbook for Patient Engagement in MedTech in the U.S.
MedTech Patient Engagement
Publications January 31, 2023
A Playbook for Patient Engagement in MedTech in the U.S.
“A Playbook for Patient Engagement in MedTech in the U.S.” is a result of amalgamating ideas, research, findings, and forecasts from industry subject matter experts that together(...)
MedTech Patient Engagement
Publications January 19, 2023
Medical Device Regulation in 2023: A Window of Opportunity
We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.
Medical Devices MedTech Regulatory
Publications January 19, 2023
What’s Next for Diabetes: Patient Engagement, Personalization, and Usable Technology
Alira Health partnered with the ADA to support this conversation and explore the most important topics emerging from patients, physicians, specialists, and patient advocates including(...)
Clinical Trials Diabetes MedTech Patient Engagement
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.